Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein

By Gorse G.J.   Patel G.B.   Newman F.K.   Mandava M.   Belshe R.B.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1170-1179

Elsevier

Access to resources Recommend Favorite

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

By Fries L.F.   Tartaglia J.   Taylor J.   Kauffman E.K.   Meignier B.   Paoletti E.   Plotkin S.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 428-434

Elsevier

Access to resources Recommend Favorite

Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system

By Oh Y.-K.   Park J.-S.   Yoon H.   Kim C.-K.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1989-1997

Elsevier

Access to resources Recommend Favorite

Recombinant BCG strains expressing the SIV mac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice

By Winter N.   Lagranderie M.   Gangloff S.   Leclerc C.   Gheorghiu M.   Gicquel B.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant

By Sinnathamby G.   Renukaradhya G.J.   Rajasekhar M.   Nayak R.   Shaila M.S.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4816-4823

Elsevier

Access to resources Recommend Favorite